SAN DIEGO — Patients presenting with severe angina but no obstructive coronary artery disease (CAD) during coronary angiography might benefit from more invasive tests that can spot microvascular ...
Chest pain may still be angina even when the main heart arteries look clear. Using cardiac stress MRI (a heart scan that measures blood flow with magnetic resonance imaging), testing uncovered small ...
A new routine test could help diagnose common heart problems in thousands of British patients. The 15-minute check, in which a wire the width of five twisted strands of hair is inserted into the heart ...
An NHS test to assess a patient's risk of heart attack is worthless, a study has found. The electrocardiogram, which records the electrical impulses produced by a heart's rhythm, is not accurate ...
The test involves sticking a wire into the heart to measure how well the blood vessels relax A NEW 20-minute test is six times more effective at detecting hidden heart problems, experts have claimed.
Is your angina viral or bacterial? Rapid diagnostic testing for angina (Trod angina) can help determine angina. Previously performed by a doctor, this test can now be done in a pharmacy. Image ...
Patients who present with typical symptoms of angina but who have a negative precardiac catheterization stress-test result have the highest rate of obstructive coronary artery disease, according to a ...
A COMMON test for the diagnosis and treatment of angina is flawed in at least a quarter of cases when used on its own, a leading heart specialist from Southampton has claimed. The condition, which is ...
In patients with suspected angina due to coronary heart disease, the greater diagnostic certainty achieved with coronary CT angiography (CTA) versus stress testing results in more appropriate use of ...
A COMMONLY used test for diagnosis and treatment of angina is flawed in at least a quarter of cases when used on its own, a leading heart specialist from Southampton claimed today. The condition, ...
CV Therapeutics Angina Drug Fails in New Heart Disease Test PALO ALTO, Calif., March 6 -- CV Therapeutics, Inc. announced today that an analysis of unblinded data from the MERLIN TIMI-36 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results